Effects of Selected Flavonoids and Caffeic Acid Derivatives on Hypoxanthine-Xanthine Oxidase-Induced Toxicity in Cultivated Human Cells

Planta Medica

Volumn 69, Issue 12, 2003, Pages 1125-1129

  Beyer, Gabriele ^a   Melzig, Matthias F ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Caffeic acid derivatives; ECV 304 cells; Flavones; Flavonols; Hypoxanthine; Radical scavenger activity; Xanthine oxidase

Indexed keywords

APIGENIN; AURANTIIN; CAFFEIC ACID DERIVATIVE; CATECHIN; CHLOROGENIC ACID; CHRYSIN; DIOSMIN; EPIGALLOCATECHIN GALLATE; FLAVONE; FLAVONOID; FLAVONOID GLYCOSIDE; HYPERIN; LUTEOLIN 7 GLUCOSIDE; MYRICETIN; NARINGENIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; ROSMARINIC ACID; RUTOSIDE; XANTHINE OXIDASE;

ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; LIPOPHILICITY;

CAFFEIC ACIDS; CELL LINE; CELL SURVIVAL; FLAVONOIDS; FREE RADICAL SCAVENGERS; HUMANS; HYPOXANTHINE; PHYTOTHERAPY; PLANTS, MEDICINAL; XANTHINE OXIDASE;

EID: 1242351798     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45194     Document Type: Article

References (17)

1. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine.; 2nd Edition Oxford: Clarendon Press, 1989
2. Miller AL. Antioxidant Flavonoids: Structure, function and clinical use. Alt Med Rev 1996; 1: 103-11
3. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000; 63: 1035-42
4. Watzl B, Rechkemmer G. Flavonoide. Ernährungs-Umschau 2001; 48: 498-502
5. Narayana KR, Reddy MS, Chaluvadi MR, Krishna DR. Bioflavonoids classification, pharmacological, biochemical effects and therapeutical potential. Ind J Pharmacol 2001; 33: 2-16
6. Hertog MGL, Hollmann PCH. Potential health effects of the dietary flavonol quercetin. European J Clin Nutr 1996; 50: 63-71
7. Knekt P, Järvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 199; 312: 487-91
8. Gräfe EU. Relative systemische Verfügbarkeit und Pharmakokinetik von Quercetin und Quercetinglycosiden (Quercetin-4′-O- glucosid und Quercetin-3-O-rutinosid) im Menschen. Ph.D. Thesis, University of Würzburg, 2001
9. Lamson DW, Brignall MS. Antioxidants and cancer III: Quercetin. Alt Med Rev 2000; 5: 96-208
10. Metz G. Flavonoide Teil III: Trotz Resorptionsschwächen gut wirksam. Pharm Ztg 2000; 145: 2206-08
11. Cos P, Li Y, Calomme M, Hu JP, Cimanga K, Van Poel B et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 1998; 61: 71-6
12. Sugihara N, Ohnishi M, Imamura M, Furuno K. Differences in antioxidative efficiency of catechins in various metal-induced lipid peroxidations in cultures hepatocytes. J Health Sci 2001; 47: 99-106
13. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Rad Biol Med 1995; 19: 481-86
14. Merfort I, Heilmann J, Weiss M, Pietta P, Gardana C. Radical scavenger activity of three flavonoid metabolites studied by inhibition of chemoluminescence in human PMNs. Planta Med 1996; 62: 289-92
15. Benoit JN, Taylor MS. Vascular reactivity following ischemia/reperfusion. Front Biosci 1997; 2: e28-33
16. Mossmann T. Rapid colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
17. Melzig MF, Löser B, Ciesielski S. Inhibition of neutrophil elastase activity by phenolic compounds from plants. Pharmazie 2001; 56: 967-70